These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive Breast Cancer: Mature Results from a Single Institution Experience. Armstrong S; Makris A; Belessiotis-Richards K; Abdul-Latif M; Ostler P; Shah N; Miles D; Tsang YM Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):362-369. PubMed ID: 38575431 [TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of stereotactic ablative radiotherapy (SABR) for metastatic lung lesions (MLLs) in comparison with a contemporaneous cohort of primary lung lesions (PLLs). Oskan F; Dzierma Y; Wagenpfeil S; Rübe C; Fleckenstein J J Thorac Dis; 2017 Mar; 9(3):742-756. PubMed ID: 28449482 [TBL] [Abstract][Full Text] [Related]
6. Improved local control following dose-escalated stereotactic ablative radiation therapy (SABR) for metastatic sarcomas: An international multi-institutional experience. Singh R; Konrad A; Roubil JG; Jenkins J; Davis J; Austin Vargo J; Gogineni E; Sharma S Radiother Oncol; 2024 Jan; 190():110020. PubMed ID: 38007042 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases. Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496 [TBL] [Abstract][Full Text] [Related]
8. The Role of Stereotactic Ablative Body Radiotherapy in Gynaecological Cancers: A Systematic Review. Mendez LC; Leung E; Cheung P; Barbera L Clin Oncol (R Coll Radiol); 2017 Jun; 29(6):378-384. PubMed ID: 28209456 [TBL] [Abstract][Full Text] [Related]
9. Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic disease. He K; Hong DS; Tang C; Sezen D; Cox L; Maleki A; Bertolet G; Nguyen QN; Comeaux NI; Schuda L; Chen D; Welsh JW Radiother Oncol; 2023 Jun; 183():109618. PubMed ID: 36921766 [TBL] [Abstract][Full Text] [Related]
11. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases. Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolization. Lee HL; Tsai JT; Chen CY; Lin YC; Ho CB; Ting LL; Kuo CC; Lai IC; Lin CY; Tang JH; Huang YM; Kao WY; Cheng SW; Shen CN; Chen SW; Chiou JF Ther Adv Med Oncol; 2019; 11():1758835919889002. PubMed ID: 31839809 [TBL] [Abstract][Full Text] [Related]
13. Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients. Upadhyay R; Klamer B; Matsui J; Chakravarthy VB; Scharschmidt T; Yeager N; Setty BA; Cripe TP; Roberts RD; Aldrink JH; Singh R; Raval RR; Palmer JD; Baliga S Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893209 [TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes of stereotactic ablative body radiotherapy on oligometastases from colorectal cancer: early results of a single institution service evaluation. Duong J; Stewart-Lord A; Nariyangadu P; Harrison M; Tsang YM BJR Open; 2022; 4(1):20210071. PubMed ID: 36105422 [TBL] [Abstract][Full Text] [Related]
15. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity. Goldsmith C; Plowman PN; Green MM; Dale RG; Price PM Radiat Oncol; 2018 Oct; 13(1):204. PubMed ID: 30340643 [TBL] [Abstract][Full Text] [Related]
16. Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE Registry. Nieuwenhuizen S; Dijkstra M; Puijk RS; Timmer FEF; Nota IM; Opperman J; van den Bemd B; Geboers B; Ruarus AH; Schouten EAC; de Vries JJJ; Scheffer HJ; van Geel AM; van Waesberghe JHTM; Swijnenburg RJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Haasbeek CJA; Meijerink MR Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503113 [TBL] [Abstract][Full Text] [Related]
17. Stereotactic ablative body radiotherapy for spinal metastasis from hepatocellular carcinoma: its oncologic outcomes and risk of vertebral compression fracture. Yoo GS; Park HC; Yu JI; Lim DH; Cho WK; Lee E; Jung SH; Han Y; Kim ES; Lee SH; Eoh W; Park SJ; Chung SS; Lee CS; Lee JH Oncotarget; 2017 Sep; 8(42):72860-72871. PubMed ID: 29069831 [TBL] [Abstract][Full Text] [Related]
18. Active breathing control guided stereotactic body ablative radiotherapy for management of liver metastases from colorectal cancer. Gamsiz H; Sager O; Uysal B; Dincoglan F; Demiral S; Colak O; Ozcan F; Dirican B; Beyzadeoglu M Acta Gastroenterol Belg; 2022; 85(3):469-475. PubMed ID: 35770280 [TBL] [Abstract][Full Text] [Related]
19. Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer. Ali M; Kwon YS; Koo K; Bruynzeel A; Pryor D; Schep DG; Huo M; Stein M; Swaminath A; Hannan R; Siva S BJU Int; 2025 Jan; 135(1):110-116. PubMed ID: 39187428 [TBL] [Abstract][Full Text] [Related]
20. Stereotactic Ablative Body Radiotherapy for the Treatment of Spinal Oligometastases. Chang JH; Gandhidasan S; Finnigan R; Whalley D; Nair R; Herschtal A; Eade T; Kneebone A; Ruben J; Foote M; Siva S Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):e119-e125. PubMed ID: 28237218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]